TROPICAL SPRUE

TROPICAL SPRUE

AT A GLANCE

1. DEFINITION

Tropical sprue is an acquired malabsorptive disorder of the small intestine associated with living in, or prolonged exposure to, certain tropical regions. An infectious or post-infectious mechanism is suspected, but no single causative organism has been established.

2. EPIDEMIOLOGY AND ETIOPATHOGENESIS

• Reported mainly in parts of South Asia, Southeast Asia and the Caribbean; residents and long-stay visitors may be affected.
• Tropical exposure raises suspicion but is not diagnostic.
• Cause remains uncertain; persistent microbial exposure and post-infectious mucosal injury are leading hypotheses, with no single confirmed pathogen.
• Mucosal injury impairs absorption, particularly of folate and vitamin B12; fat and other micronutrient malabsorption may occur in established disease.
• Histology overlaps with coeliac disease, enteric infections and other causes of villous atrophy.

3. CLINICAL FEATURES

4. DIAGNOSTIC APPROACH

4.1 Initial assessment

• Assess hydration, haemodynamic status, weight change, dietary intake and severity of malnutrition.
• Initial tests: CBC with indices, renal function/electrolytes, liver profile, albumin, iron studies, folate and vitamin B12; add blood film if anaemia is unclear.
• If B12 status is equivocal, consider methylmalonic acid where available, interpreting alongside renal function.
• Check additional deficiencies as indicated: calcium, magnesium, phosphate, vitamin D and fat-soluble vitamins.
• Use exposure- and region-guided stool/infectious testing, including Giardia and other parasites/protozoa; consider bacterial causes and HIV where appropriate.

4.2 Establishing the diagnosis

• Require a compatible tropical exposure history and clinical syndrome of malabsorption; exposure alone is insufficient.
• Exclude key mimics, especially coeliac disease and enteric infections. Coeliac testing: tTG-IgA plus total IgA; use IgG-based tests if IgA deficient and interpret according to gluten exposure.
• When indicated, perform upper endoscopy with multiple duodenal biopsies. Villous blunting/atrophy, crypt changes and chronic inflammation may support enteropathy but are nonspecific.
• Interpret biopsy with serology, stool results, medication history, immune status and clinical context; biopsy alone does not establish tropical sprue.
• Treatment response may support—but does not prove—the diagnosis. Persistent symptoms, atypical features or poor response require reassessment.

4.3 Practical diagnostic pathway

• Chronic diarrhoea with weight loss/malabsorption → assess severity, hydration, nutrition and tropical exposure.
• Suspected malabsorption → test folate/B12 and other relevant deficiencies; investigate enteric infections based on exposure.
• Possible villous atrophy → coeliac serology (including total IgA) and duodenal biopsies when indicated.
• Villous atrophy with drug exposure or immune risk → review medications and assess medication-related/immune-mediated enteropathy.
• No meaningful improvement → review adherence, deficiencies, infection, coeliac disease and other causes; consider gastroenterology input.

5.Differential diagnosis

6. MANAGEMENT

6.1 Stabilisation and nutritional rehabilitation

• Correct dehydration and electrolyte abnormalities. Consider hospital care for severe dehydration, major electrolyte disturbance, symptomatic anaemia or inability to maintain oral intake.
• Provide adequate calories and protein; monitor intake and weight. Replace documented or strongly suspected deficiencies, including iron and other micronutrients as indicated.
• Consider dietitian input for substantial weight loss, severe malnutrition or persistent deficits.

6.2 Folate and vitamin B12

• Folic acid: 5 mg orally daily is a commonly cited adult regimen; individualise duration to severity, response and biochemical recovery.
• Assess B12 and replace before or concurrently when deficiency is possible. Do not give folate alone if B12 deficiency has not been excluded, because neurological injury may progress.
• Choose an established oral or parenteral B12 regimen based on severity, neurological involvement and likely absorption; favour prompt parenteral treatment when significant neurological features or unreliable oral absorption are present.
• Follow symptoms, weight and relevant laboratory markers; correction of anaemia alone does not prove full nutritional or mucosal recovery.

6.3 Antibiotic treatment: evidence and practical cautions

• Antibiotics are commonly used because an infectious/post-infectious mechanism is suspected, but evidence is limited and no single regimen is validated for every patient.
• References describe tetracycline 250 mg orally four times daily; courses up to 6 months have been reported. Doxycycline is an alternative, but the cited summary does not specify a tropical-sprue dose.
• TMP–SMX or quinolones are described as alternatives in some reviews; comparative evidence is limited. Do not treat them as automatic substitutes.
• Individualise agent and duration to severity, illness duration, response, age, pregnancy status, comorbidities, interactions and local antimicrobial guidance. Check contraindications and current prescribing information.
• Before treatment, confirm that the working diagnosis is sufficiently supported and consider antimicrobial stewardship/specialist advice for prolonged or alternative regimens.
• If there is no meaningful improvement by about 4 weeks, reassess diagnosis, adherence, nutritional replacement, enteric infection, coeliac disease, drug-related enteropathy and other causes; do not automatically escalate or extend antibiotics.
• Before retreatment for relapse, reassess diagnosis, ongoing exposure, adherence, persistent deficiencies and alternative causes.

Note: Tropical sprue lacks a single confirmed causative organism and a universally validated treatment regimen. Management recommendations  cited are based on older clinical references; antibiotic selection and duration require patient-specific review and local prescribing guidance.

7. FOLLOW-UP AND RESPONSE

8. COMPLICATIONS

• Severe weight loss, protein-calorie malnutrition and dehydration.
• Folate/B12 deficiency anaemia; B12-related neurological injury may be irreversible if treatment is delayed.
• Other micronutrient deficiencies, including fat-soluble vitamins, calcium and vitamin D in substantial malabsorption.
• Relapse or persistent symptoms requiring diagnostic reassessment.

9. PRACTICAL CLINICAL PEARLS

• Tropical exposure plus malabsorption is a clue—not a diagnosis.
• Villous atrophy is nonspecific; tropical sprue, coeliac disease, infections and drug-related enteropathies can overlap histologically.
• Assess both folate and vitamin B12; mixed deficiencies may produce a normal MCV.
• Folate may produce a striking haematological response, but it must not delay B12 treatment when B12 deficiency is possible.
• Failure to improve should trigger a diagnostic pause, not reflexive antibiotic escalation.
• Prolonged antibiotics should be selected and monitored deliberately; historical regimens should not be presented as universally validated contemporary protocols.

REFERENCES

Core textbook

1. Rubin DC. Chapter 336: Disorders of Absorption. In: Loscalzo J, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, editors. Harrison’s Principles of Internal Medicine. 22nd ed. McGraw Hill; 2025. 

2. Ramakrishna BS. “Tropical Diarrhea and Malabsorption.” In: Feldman M, Friedman LS, Brandt LJ, editors. Sleisenger and Fordtran’s Gastrointestinal and Liver Disease. 11th ed. Elsevier; 2021. Chapter 108..

3. Malik Z. Tropical Sprue. Merck Manual Professional Edition. Last reviewed March 2025. https://www.merckmanuals.com/professional/gastrointestinal-disorders/malabsorption-syndromes/tropical-sprue

4. Rubio-Tapia A, et al. American College of Gastroenterology Guidelines Update: Diagnosis and Management of Celiac Disease. Am J Gastroenterol. 2023;118(1):59–76. doi:10.14309/ajg.0000000000002075.